Actuate Therapeutics Inc
ACTU | NASDAQ
$0.86
-$0.05 (-5.21%)
Sep 22, 2026, 12:01 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -20.77M | -21.83M | -22.49M | -24.37M | -24.29M | -23.75M | -25.16M | -26.22M | -27.3M | -27.45M | -24.97M | -17.36M | -10.88M | -5.3M |
Interest Income | 339.84K | 319.36K | 287.71K | 266.24K | 277.02K | 261.13K | 222.29K | 163.87K | 209.06K | 315.81K | 352.67K | 292.98K | 167.04K | 51.65K |
Pretax Income | -20.45M | -21.54M | -22.23M | -24.12M | -24.68M | -25.31M | -27.29M | -28.45M | -28.82M | -27.77M | -24.74M | -17.13M | -10.79M | -5.27M |
Net Income | -20.45M | -21.54M | -22.23M | -24.12M | -24.68M | -25.31M | -27.29M | -28.45M | -28.82M | -27.77M | -24.74M | -17.13M | -10.79M | -5.27M |
Selling & General & Admin | 11.83M | 12.2M | 12.2M | 12.52M | 10.86M | 8.72M | 6.48M | 4.58M | 3.66M | 3.4M | 3.27M | 2.3M | 1.58M | 774.8K |
Research & Development | 8.94M | 9.64M | 10.29M | 11.85M | 13.43M | 15.04M | 18.68M | 21.64M | 23.64M | 24.05M | 21.71M | 15.06M | 9.3M | 4.52M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | 0 | 0 | n/a |
Operating Expenses | 20.77M | 21.83M | 22.49M | 24.37M | 24.29M | 23.75M | 25.16M | 26.22M | 27.3M | 27.45M | 24.97M | 17.36M | 10.88M | 5.3M |
Interest Expense | 20.25K | 20.25K | 20.25K | 20.26K | 18.69K | 18.7K | 18.72K | 18.7K | 20.28K | 20.26K | 43.64K | 38.58K | 33.52K | 28.45K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.77M | 21.83M | 22.49M | 24.37M | 24.29M | 23.75M | 25.16M | 26.22M | 27.3M | 27.45M | 24.97M | 17.36M | 10.88M | 5.3M |
Income Tax Expense | 800 | 800 | 800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 23.87M | 23.54M | 23.25M | 21.39M | 19.65M | 19.5M | 19.51M | 19.51M | 19.53M | 15.49M | 15.26M | 15.49M | 14.22M | 13.39M |
Shares Outstanding (Diluted) | 23.87M | 23.54M | 23.25M | 21.39M | 19.65M | 19.5M | 19.51M | 19.51M | 19.53M | 15.49M | 15.26M | 15.49M | 14.22M | 13.4M |
EPS (Basic) | -0.89 | -0.99 | -1.07 | -1.47 | -1.77 | -1.81 | -2.03 | -1.93 | -1.79 | -1.84 | -1.69 | -1.19 | -0.78 | -0.39 |
EPS (Diluted) | -0.89 | -0.99 | -1.07 | -1.47 | -1.77 | -1.81 | -2.03 | -1.93 | -1.79 | -1.84 | -1.69 | -1.19 | -0.78 | -0.39 |
EBITDA | -20.48M | -21.52M | -22.21M | -23.98M | -24.55M | -25.17M | -27.15M | -28.42M | -28.65M | -22.01M | -13.7M | -6.1M | 93.5K | 28.3K |
EBIT | -20.48M | -21.52M | -22.21M | -24.1M | -24.66M | -25.29M | -27.27M | -28.43M | -28.8M | -27.75M | -24.73M | -17.12M | -10.79M | -5.27M |
Depreciation & Amortization | n/a | n/a | n/a | 118.12K | 118.12K | 118.12K | 118.12K | 8.09K | 150.9K | 5.74M | 11.03M | 11.03M | 10.88M | 5.3M |
Add to Watchlist
Select watchlists to add or remove ACTU